Top Markets
#1 0G 0G +32.75%
#2 Zora Zora +23.49%
#3 Nockchain Nockchain +20.21%
#4 Fake World Assets Fake World Assets +19.05%
#5 Axelar Axelar +18.61%
#6 Full Moon Full Moon +17.70%
#7 Merlin's Seal BTC Merlin's Seal BTC +15.95%
#8 Notcoin Notcoin +15.90%
#9 ADO Protocol ADO Protocol +15.68%
#10 SAFEcoin SAFEcoin +14.51%
Coin of the day
0G 0G
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Classement en actions #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Prix de l'action
$8.46
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$514.33M
Changement (1 jour)
-2.08%
Changement (1 an)
128.03%
Pays
US
Échange Kyverna Therapeutics, Inc. (KYTX)

Catégorie

Healthcare
Historique du prix de l'action pour Kyverna Therapeutics, Inc. (KYTX)
Prix de clôture le plus élevé : $8.33 le 2026-08-01

Prix de clôture le plus bas : $28.70 le 2024-02-01
Historique du prix de l'action de Kyverna Therapeutics, Inc. de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -5.16%
2025 89.56%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH